Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel H Solomon, MD, MPH
Brigham and Women's Hospital
Principal Investigator - Ellen M. Gravallese, MD
University of Massachusetts, Worcester
Principal Investigator - Jonathan Kay, MD
University of Massachusetts, Worcester
Principal Investigator - Marcy B. Bolster, M.D.
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2011
- Primary completion
- 30 Jul 2015
- Completion
- 28 Jul 2016
- Last update posted
- 11 Apr 2017
- Registered enrollment
- 26
- Registry id
- NCT01400516
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.